Kagehiro Amano

1.1k total citations
84 papers, 765 citations indexed

About

Kagehiro Amano is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Kagehiro Amano has authored 84 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Hematology, 21 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in Kagehiro Amano's work include Hemophilia Treatment and Research (59 papers), Platelet Disorders and Treatments (30 papers) and Blood Coagulation and Thrombosis Mechanisms (30 papers). Kagehiro Amano is often cited by papers focused on Hemophilia Treatment and Research (59 papers), Platelet Disorders and Treatments (30 papers) and Blood Coagulation and Thrombosis Mechanisms (30 papers). Kagehiro Amano collaborates with scholars based in Japan, United States and Germany. Kagehiro Amano's co-authors include Katsuyuki Fukutake, Hiroshi Inaba, Midori Shima, Morio Arai, Keiji Nogami, Randal J. Kaufman, K Michaelides, David Ginsburg, R. Schwaab and Satoshi Higasa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and AIDS.

In The Last Decade

Kagehiro Amano

62 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kagehiro Amano Japan 16 690 247 109 55 41 84 765
Sandrine Meunier France 12 346 0.5× 92 0.4× 171 1.6× 32 0.6× 19 0.5× 45 578
B. Brand Switzerland 12 499 0.7× 116 0.5× 92 0.8× 14 0.3× 57 1.4× 13 634
Masahiro Takeyama Japan 12 406 0.6× 141 0.6× 22 0.2× 31 0.6× 50 1.2× 64 477
Kate Nesbitt Canada 10 187 0.3× 30 0.1× 77 0.7× 39 0.7× 36 0.9× 19 379
P. Saidi United States 9 258 0.4× 124 0.5× 28 0.3× 20 0.4× 12 0.3× 9 353
Clarisse Lopes de Castro Lobo Brazil 12 360 0.5× 409 1.7× 38 0.3× 12 0.2× 10 0.2× 32 482
H. Lenk Germany 13 545 0.8× 161 0.7× 52 0.5× 4 0.1× 44 1.1× 36 620
Andrés Quezada Spain 5 193 0.3× 22 0.1× 261 2.4× 108 2.0× 22 0.5× 13 424
Paul Moorehead Canada 10 155 0.2× 43 0.2× 41 0.4× 21 0.4× 20 0.5× 30 285
Emma Drašar United Kingdom 13 463 0.7× 556 2.3× 82 0.8× 3 0.1× 15 0.4× 25 655

Countries citing papers authored by Kagehiro Amano

Since Specialization
Citations

This map shows the geographic impact of Kagehiro Amano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kagehiro Amano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kagehiro Amano more than expected).

Fields of papers citing papers by Kagehiro Amano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kagehiro Amano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kagehiro Amano. The network helps show where Kagehiro Amano may publish in the future.

Co-authorship network of co-authors of Kagehiro Amano

This figure shows the co-authorship network connecting the top 25 collaborators of Kagehiro Amano. A scholar is included among the top collaborators of Kagehiro Amano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kagehiro Amano. Kagehiro Amano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Weyand, Angela C., Christoph Königs, Sandrine Meunier, et al.. (2024). Treatment of Bleeding Episodes With Efanesoctocog Alfa in Patients With Severe Haemophilia A in the Phase 3 XTEND-1 Study. Hämostaseologie. 1 indexed citations
3.
Kawado, Miyuki, Makiko Mieno, Shuji Hashimoto, et al.. (2023). HIV RNA and HCV RNA Levels, and Mortality: The Japan Cohort Study of HIV Patients Infected through Blood Products. The Open AIDS Journal. 17(1).
4.
Nogami, Keiji, Teruhisa Fujii, Akihiro Sawada, et al.. (2023). Association of physical activity with bleeding events and safety in patients with haemophilia A starting emicizumab prophylaxis: an interim analysis of the TSUBASA study. International Journal of Hematology. 119(1). 14–23. 6 indexed citations
5.
Yamaguchi, Tomoko, Satoru Nagatoishi, Hiroshi Inaba, et al.. (2023). In vitro validation of chromogenic substrate assay for evaluation of surrogate FVIII-activity of emicizumab. Thrombosis Research. 222. 131–139. 6 indexed citations
6.
7.
Ogawa, Yoshiyuki, Kagehiro Amano, Norihiro Okada, et al.. (2022). ORIHIME study: real-world treatment patterns and clinical outcomes of 338 patients with acquired hemophilia A from a Japanese administrative database. International Journal of Hematology. 117(1). 44–55. 7 indexed citations
8.
9.
Tamura, Akihiro, Sayaka Nakamura, Nobuyuki Yamamoto, et al.. (2021). Early elevation of factor IX level in japanese brothers with Haemophilia B Leyden who are carrying c. ‐35 g > a mutations in the promoter region of F9. Haemophilia. 27(4). e510–e512. 2 indexed citations
10.
Amano, Kagehiro, et al.. (2021). Genetic analysis of carrier status in female members of Japanese hemophilia families. Journal of Thrombosis and Haemostasis. 19(6). 1493–1505. 2 indexed citations
11.
Inaba, Hiroshi, et al.. (2021). Coagulation assay discrepancies in Japanese patients with non-severe hemophilia A. International Journal of Hematology. 115(2). 173–187. 2 indexed citations
12.
Tiede, Andreas, Paul Giangrande, Jerome Teitel, et al.. (2019). Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: A global expert consensus statement. Haemophilia. 25(6). 969–978. 27 indexed citations
13.
Yada, Koji, Keiji Nogami, Takehisa Kitazawa, et al.. (2018). Emicizumab‐mediated haemostatic function in patients with haemophilia A is down‐regulated by activated protein C through inactivation of activated factor V. British Journal of Haematology. 183(2). 257–266. 14 indexed citations
14.
Inaba, Hiroshi, et al.. (2017). Identification of deep intronic individual variants in patients with hemophilia A by next‐generation sequencing of the whole factor VIII gene. Research and Practice in Thrombosis and Haemostasis. 1(2). 264–274. 19 indexed citations
15.
Inaba, Hiroshi, et al.. (2008). Features of factor VIII activity measurement in Arg531His mutant detected in patients with mild hemophilia A. Japanese Journal of Thrombosis and Hemostasis. 19(6). 788–795.
16.
Inaba, Hiroshi, et al.. (2007). . Japanese Journal of Thrombosis and Hemostasis. 18(2). 166–174.
17.
18.
Inaba, Hiroshi, et al.. (2003). Five Novel and four recurrent point mutations in the antithrombin gene causing venous thrombosis. International Journal of Hematology. 78(1). 79–83. 11 indexed citations
19.
Watanabe, Jun, et al.. (2001). . Japanese Journal of Thrombosis and Hemostasis. 12(1). 39–46. 1 indexed citations
20.
Amano, Kagehiro, et al.. (1995). Autoantibody to factor VIII that has less reactivity to factor Vlll/von Willebrand Factor Complex. American Journal of Hematology. 49(4). 310–317. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandrine Meunier Breakdown of academic impact, for papers by B. Brand Breakdown of academic impact, for papers by Masahiro Takeyama Breakdown of academic impact, for papers by Kate Nesbitt Breakdown of academic impact, for papers by P. Saidi Breakdown of academic impact, for papers by Clarisse Lopes de Castro Lobo Breakdown of academic impact, for papers by H. Lenk Breakdown of academic impact, for papers by Andrés Quezada Breakdown of academic impact, for papers by Paul Moorehead Breakdown of academic impact, for papers by Emma Drašar
Rankless by CCL
2026